Literature DB >> 28624714

Patient reported outcomes of autologous fat grafting after breast cancer surgery.

A W W Brown1, M Kabir2, K A Sherman2, F Meybodi2, J R French2, E B Elder2.   

Abstract

INTRODUCTION: Autologous fat grafting (AFG) can be used as an adjunct in breast cancer surgery to improve contour defects. Few previous studies have assessed patient reported outcomes (PROs) for AFG. This study analysed AFG use and assessed PROs in terms of physical and psychosocial well-being.
MATERIALS AND METHODS: All patients undergoing AFG were identified from a prospective database and asked to complete the validated BREAST-Q questionnaire and a tool to assess patient-perceived change after AFG (5-point Likert-type scale). Descriptive statistics were computed for all BREAST-Q and perceived change subscales. Independent sample t-tests were conducted to compare scores on each of the BREAST-Q and perceived change subscales by type of breast cancer surgery and radiotherapy status.
RESULTS: 156 AFG sessions were performed over 4 years on 119 breasts in 88 patients. Fifty-seven patients received AFG after reconstruction and 19 after breast conserving surgery. Forty-six patients (52%) completed the questionnaire. BREAST-Q scores (out of 100) and patient-perceived change after AFG (out of 5) were respectively: 54 and 4.0 for Breast satisfaction, 69 and 3.3 for Physical well-being and 60 and 3.6 for Psychosocial well-being. Radiotherapy status and type of surgery made little difference. Number of AFG procedures positively correlated with perceived improvement. DISCUSSION: Autologous fat grafting was associated with improved patient satisfaction despite small volumes transferred. BREAST-Q scores were comparable with previously published series on reconstructive breast surgery. Perceived change after AFG was no different in patients receiving radiotherapy.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; Breast reconstruction; Fat grafting; Lipofilling; Patient reported outcome measures

Mesh:

Year:  2017        PMID: 28624714     DOI: 10.1016/j.breast.2017.06.006

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  10 in total

Review 1.  Application of Fat Grafting in Cosmetic Breast Surgery.

Authors:  Matthew J Davis; Aurelia T Perdanasari; Amjed Abu-Ghname; Santiago R Gonzalez; Edward Chamata; Charalambos K Rammos; Sebastian J Winocour
Journal:  Semin Plast Surg       Date:  2020-02-15       Impact factor: 2.314

Review 2.  Latest Trends in Subpectoral Breast Reconstruction.

Authors:  Christine Oh; Sebastian J Winocour; Valerie Lemaine
Journal:  Semin Plast Surg       Date:  2019-10-17       Impact factor: 2.314

Review 3.  Oncological safety of reconstruction with autologous fat grafting in breast cancer patients: a systematic review and meta-analysis.

Authors:  Jiale Sun; He Liang; Dongcai Lin; Bing Han; Tiran Zhang; Jidong Gao
Journal:  Int J Clin Oncol       Date:  2022-07-05       Impact factor: 3.850

4.  The Prepectoral, Hybrid Breast Reconstruction: The Synergy of Lipofilling and Breast Implants.

Authors:  Filip B J L Stillaert; Bernd Lannau; Koenraad Van Landuyt; Phillip N Blondeel
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-07-23

Review 5.  Implant-Based Breast Reconstruction after Mastectomy, from the Subpectoral to the Prepectoral Approach: An Evidence-Based Change of Mind?

Authors:  Andrea Weinzierl; Daniel Schmauss; Davide Brucato; Yves Harder
Journal:  J Clin Med       Date:  2022-05-30       Impact factor: 4.964

6.  Identifying breast cancer recurrence histories via patient-reported outcomes.

Authors:  J David Beatty; Qin Sun; Daniel Markowitz; Jessica Chubak; Bin Huang; Ruth Etzioni
Journal:  J Cancer Surviv       Date:  2021-04-14       Impact factor: 4.442

7.  Meta-analysis of the oncological safety of autologous fat transfer after breast cancer.

Authors:  T K Krastev; S J Schop; J Hommes; A A Piatkowski; E M Heuts; R R W J van der Hulst
Journal:  Br J Surg       Date:  2018-06-05       Impact factor: 6.939

8.  Breast Reconstruction-Prospective Follow up on Breast Cancer Patients' Health-Related Quality of Life.

Authors:  Mervi Rautalin; Tiina Jahkola; Risto P Roine
Journal:  World J Surg       Date:  2022-01-09       Impact factor: 3.352

9.  Adipose-derived stem cells (ADSCs) inhibit the expression of anti-apoptosis proteins through up-regulation of ATF4 on breast cancer cells.

Authors:  Jing Ren; Weishu Kong; Feng Lu; Ye Li
Journal:  Ann Transl Med       Date:  2021-08

10.  Influence of Tamoxifen on Different Biological Pathways in Tumorigenesis and Transformation in Adipose-Derived Stem Cells, Mammary Cells and Mammary Carcinoma Cell Lines-An In Vitro Study.

Authors:  Frederik Schlottmann; Vesna Bucan; Sarah Strauß; Felix Koop; Peter M Vogt; Tobias R Mett
Journal:  Cells       Date:  2022-09-01       Impact factor: 7.666

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.